Verana Health
PrivateLast Round
Strategic
Jan 8, 2026
Total Funding Raised
$339.8M
Momentum
Top 50%
of companies Caplight tracks
Company Overview
Verana Health is a healthcare technology company that operates a data insights platform designed to accelerate medical research and optimize the development of drugs and devices.
Sector
Healthcare & Life Sciences
Verticals
Healthcare Analytics, EHR & EMR, Clinical Trials, Compliance, Medical AI
Business Model
B2B
Customer Profile
Data as a Service, Services & Consulting, Subscription SaaS
AI Layer
Application
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Verana Health Comparables
Compare Verana Health with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| OM1 | 88% | |
| OMNY Health | 86% | |
| nference | 85% |
Verana Health Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Strategic | Jan 8, 2026 | ||||
| Series E | Jan 14, 2022 | ||||
| Series D | Feb 5, 2020 | ||||
| Series C | Jul 31, 2018 | ||||
| Series B | Feb 9, 2015 |
Key People
Founding team and executive leadership
Verana Health Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Define Ventures | Series D |
| Merck Global Health Innovation Fund | Series E |
| Breyer Capital | Series E |
| Bain Capital Ventures | Series D |
| GV | Series C, Series E, Series D |
| Waycross Ventures | Series B |
| Lagunita Biosciences | Series B, Series C |
Market signals
Structured signals derived from secondary market and firmographic data.
- Apr 29, 2026
Developing Agent Claire, an AI assistant for medical practices.
- Mar 10, 2026
Launched an Imaging Consortium with leading Academic Medical Centers.
Recent news
Latest coverage and updates
- partners_withOct 8, 2026
Verana Health partners with Bitfount Ltd to simplify ophthalmic clinical trial prescreening in California on Oct 8th '26
- launchesOct 1, 2026
Verana Health launches Retinal Vein Occlusion and Stargardt Disease datasets
- partners_withOct 1, 2026
Verana Health partners with American Academy of Ophthalmology through the exclusive IRIS Registry data partnership in California on Oct 1st '26
- launchesSep 24, 2026
Verana Health launched AI agents on Sep 24th '26.
Verana Health Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Request accessFrequently Asked Questions
Common questions about Verana Health's valuation, stock price, and market status.
Is Verana Health a public or private company?
Verana Health is a private company.
What is the current stock price of Verana Health?
Verana Health is a private company, so its shares have no public market price. Caplight tracks Verana Health's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is Verana Health worth (valuation)?
Valuation information for Verana Health is not publicly available.
Can I buy Verana Health stock?
Verana Health shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was Verana Health's last funding round?
Verana Health's most recent funding round was Strategic on January 8, 2026.
Who are the main investors in Verana Health?
Key investors in Verana Health include GV, Novo Holdings, Novo Growth, Johnson & Johnson Innovation - JJDC, Johnson & Johnson Innovation - JJDC, Inc..
Will Verana Health IPO soon?
No public IPO plans have been announced for Verana Health.
How can I track Verana Health secondary market activity?
Caplight tracks bids, offers, and trades in Verana Health's shares on secondary markets.